{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T02:34:29Z","timestamp":1773628469760,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":2188,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005890","name":"Ministry of Health of China","doi-asserted-by":"publisher","award":["AWS15J006"],"award-info":[{"award-number":["AWS15J006"]}],"id":[{"id":"10.13039\/501100005890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21AI111152"],"award-info":[{"award-number":["R21AI111152"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"New York Blood Center","award":["NYB000414"],"award-info":[{"award-number":["NYB000414"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.micinf.2017.08.010","type":"journal-article","created":{"date-parts":[[2017,9,10]],"date-time":"2017-09-10T14:30:57Z","timestamp":1505053857000},"page":"641-647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Highly conserved M2e and hemagglutinin epitope-based recombinant proteins induce protection against influenza virus infection"],"prefix":"10.1016","volume":"19","author":[{"given":"Yan","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nianping","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanbo","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shibo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanying","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2017.08.010_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJMra1208802","article-title":"Pandemic preparedness and response \u2013 lessons from the H1N1 influenza of 2009","volume":"370","author":"Fineberg","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2017.08.010_bib2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.aogh.2015.08.014","article-title":"Treatment and prevention of pandemic H1N1 influenza","volume":"81","author":"Rewar","year":"2015","journal-title":"Ann Glob Health"},{"key":"10.1016\/j.micinf.2017.08.010_bib3","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3201\/eid2308.170640","article-title":"Preliminary epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus, China, 2017","volume":"23","author":"Zhou","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.micinf.2017.08.010_bib4","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1473-3099(17)30323-7","article-title":"Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series","volume":"17","author":"Wang","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.micinf.2017.08.010_bib5","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.27.30568","article-title":"Epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus in Guangdong, 2016 to 2017","volume":"22","author":"Kang","year":"2017","journal-title":"Euro Surveill"},{"key":"10.1016\/j.micinf.2017.08.010_bib6","series-title":"As deadly human bird flu cases surge and new U.S. cases are discovered, world pandemic fears grow; how to prepare","author":"Paratus Business News","year":"2017"},{"key":"10.1016\/j.micinf.2017.08.010_bib7","series-title":"Human infection with avian influenza A(H7N9) virus \u2013 China","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.micinf.2017.08.010_bib8","series-title":"Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003\u20132017","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.micinf.2017.08.010_bib9","series-title":"Bird flu strain taking a toll on humans","author":"Normile","year":"2017"},{"key":"10.1016\/j.micinf.2017.08.010_bib10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.chom.2015.02.012","article-title":"Influenza vaccines: challenges and solutions","volume":"17","author":"Houser","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micinf.2017.08.010_bib11","article-title":"Is it possible to develop \u201cuniversal\u201d influenza virus vaccine? Toward a universal influenza virus vaccine: potential target antigens and critical aspects for vaccine development","author":"Krammer","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.micinf.2017.08.010_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejpb.2015.05.023","article-title":"Current and next generation influenza vaccines: formulation and production strategies","volume":"94","author":"Soema","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.micinf.2017.08.010_bib13","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1016\/j.vaccine.2009.07.007","article-title":"M2e-based universal influenza A vaccine","volume":"27","author":"Fiers","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2017.08.010_bib14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.micinf.2010.01.001","article-title":"Research and development of universal influenza vaccines","volume":"12","author":"Du","year":"2010","journal-title":"Microbes Infect"},{"key":"10.1016\/j.micinf.2017.08.010_bib15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.virol.2017.06.001","article-title":"Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge","volume":"509","author":"Deng","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2017.08.010_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/21655979.2015.1126017","article-title":"High immunogenicity of plant-produced candidate influenza vaccine based on the M2e peptide fused to flagellin","volume":"7","author":"Mardanova","year":"2016","journal-title":"Bioengineered"},{"key":"10.1016\/j.micinf.2017.08.010_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5582\/bst.2015.01060","article-title":"High copy numbers and N terminal insertion position of influenza A M2e fused with hepatitis B core antigen enhanced immunogenicity","volume":"9","author":"Sun","year":"2015","journal-title":"Biosci Trends"},{"key":"10.1016\/j.micinf.2017.08.010_bib18","doi-asserted-by":"crossref","first-page":"e0119520","DOI":"10.1371\/journal.pone.0119520","article-title":"Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin","volume":"10","author":"Stepanova","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2017.08.010_bib19","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.vaccine.2015.04.066","volume":"33","author":"Ravin","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2017.08.010_bib20","article-title":"Is it possible to develop a \u201cuniversal\u201d influenza virus vaccine? Potential for a universal influenza vaccine","author":"Crowe","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.micinf.2017.08.010_bib21","article-title":"Is it possible to develop a \u201cuniversal\u201d influenza virus vaccine? Outflanking antibody immunodominance on the road to universal influenza vaccination","author":"Angeletti","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.micinf.2017.08.010_bib22","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1038\/emi.2016.51","article-title":"Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B","volume":"5","author":"Gong","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.micinf.2017.08.010_bib23","doi-asserted-by":"crossref","first-page":"18979","DOI":"10.1073\/pnas.1013387107","article-title":"Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes","volume":"107","author":"Wang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2017.08.010_bib24","doi-asserted-by":"crossref","first-page":"13133","DOI":"10.1073\/pnas.1414070111","article-title":"Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans","volume":"111","author":"Ellebedy","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2017.08.010_bib25","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1016\/j.vaccine.2010.08.049","article-title":"Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant","volume":"28","author":"Zhao","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2017.08.010_bib26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.virol.2009.07.018","article-title":"Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity","volume":"393","author":"Du","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2017.08.010_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01651-16","article-title":"Recombinant receptor-binding domains of multiple middle east respiratory syndrome coronaviruses (MERS-CoVs) induce cross-neutralizing antibodies against divergent human and camel MERS-CoVs and antibody escape mutants","volume":"91","author":"Tai","year":"2017","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2017.08.010_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13473","article-title":"Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines","volume":"7","author":"Du","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.micinf.2017.08.010_bib29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.virol.2016.10.005","article-title":"A\u00a0recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection","volume":"499","author":"Tai","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2017.08.010_bib30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/cmi.2015.03","article-title":"Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against middle east respiratory syndrome coronavirus","volume":"13","author":"Zhang","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.micinf.2017.08.010_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1743-422X-7-9","article-title":"An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses","volume":"7","author":"Zhao","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.micinf.2017.08.010_bib32","first-page":"79","article-title":"What intravenous treatment for myocardial infarction: beta-blockers, nitrates or thrombolysis?","volume":"106","author":"Heikkila","year":"1990","journal-title":"Duodecim"},{"key":"10.1016\/j.micinf.2017.08.010_bib33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fmicb.2014.00172","article-title":"Recombinant protein expression in Escherichia coli: advances and challenges","volume":"5","author":"Rosano","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.micinf.2017.08.010_bib34","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.160196","article-title":"High-throughput recombinant protein expression in Escherichia coli: current status and future perspectives","volume":"6","author":"Jia","year":"2016","journal-title":"Open Biol"},{"key":"10.1016\/j.micinf.2017.08.010_bib35","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cmi.2017.02.009","article-title":"Universal influenza virus vaccines and therapeutic antibodies","volume":"23","author":"Nachbagauer","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.micinf.2017.08.010_bib36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1743-422X-7-151","article-title":"An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus","volume":"7","author":"Zhao","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.micinf.2017.08.010_bib37","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1038\/emi.2015.22","article-title":"An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus","volume":"4","author":"Leung","year":"2015","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.micinf.2017.08.010_bib38","doi-asserted-by":"crossref","first-page":"e0156418","DOI":"10.1371\/journal.pone.0156418","article-title":"Epitope mapping of avian influenza M2e protein: different species recognise various E","volume":"11","author":"Hasan","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2017.08.010_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4110\/in.2015.15.5.213","article-title":"Mechanisms of cross-protection by influenza virus M2-based vaccines","volume":"15","author":"Lee","year":"2015","journal-title":"Immune Netw"},{"key":"10.1016\/j.micinf.2017.08.010_bib40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/14760584.2017.1240041","article-title":"M2-based influenza vaccines: recent advances and clinical potential","volume":"16","author":"Kolpe","year":"2017","journal-title":"Expert Rev Vaccines"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457917301417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457917301417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T18:04:23Z","timestamp":1701194663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457917301417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1286457917301417"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2017.08.010","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly conserved M2e and hemagglutinin epitope-based recombinant proteins induce protection against influenza virus infection","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2017.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Institut Pasteur. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}